US 8940758
Fused heterocyclic compounds
granted A61KA61K31/4353A61K31/4355
Quick answer
US patent 8940758 (Fused heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4353, A61K31/4355, A61K31/437, A61K31/4427